Hoover Institution Stanford University
. . . ideas defining a free society
Twitter icon Facebook icon YouTube icon Apple logo Scribd icon RSS icon

News
News
hoover daily report
slide shows
news releases
what’s new
calendar

Hoover Daily Report by topic: Biotechnology

November 8, 2011 | Nature Biotechnology
news » hoover daily report

A label we don't need

by Henry I. Miller (Robert Wesson Fellow in Scientific Philosophy and Public Policy) and Drew L. Kershen
The United Nations agency that sets food standards—the Codex Alimentarius—recently reached an impasse on the labeling of food containing products derived from recombinant DNA technology...
November 3, 2011 | Forbes.com
news » hoover daily report

If Obama Were Serious About Stimulating The Economy, Regulatory Reform Would Make A Difference

by Henry I. Miller (Robert Wesson Fellow in Scientific Philosophy and Public Policy)
Instead, we have gotten (and are getting) profligate spending and wasteful, unscientific, nanny-state policies that inhibit innovation, discourage R&D, blunt wealth creation and kill jobs...
October 18, 2011 | Forbes.com
news » hoover daily report

A Confused And Confusing CDC

by Henry I. Miller (Robert Wesson Fellow in Scientific Philosophy and Public Policy) and Jeff Stier
Faced with the question of whether to add a meningitis vaccine to the schedule of vaccines routinely recommended for infants, officials at the CDC are asking the wrong questions to the wrong people, and in a non-transparent way...
October 4, 2011 | USA Today
news » hoover daily report

Misleading neonatal data distort rankings

by Scott W. Atlas (David and Joan Traitel Senior Fellow and member of the Working Group on Health Care Policy)
Infant mortality rates are extremely misleading, contaminated by factors unrelated to health care quality, and plagued by inconsistencies and gross inaccuracies, all of which specifically disadvantage the United States...
September 15, 2011
news » hoover daily report

FDA Thumps Industry, Patients Feel the Pain

by Henry I. Miller (Robert Wesson Fellow in Scientific Philosophy and Public Policy)
As the agency's demands escalate, fewer drugs and devices will make it to market...
September 8, 2011 | Nature Biotechnology (subscription required)
news » hoover daily report

Why an abbreviated FDA pathway for biosimilars is overhyped

by Henry I. Miller (Robert Wesson Fellow in Scientific Philosophy and Public Policy)
September 13, 2011 | Corner (National Review Online)
news » hoover daily report

Gardasil and the GOP

by Henry I. Miller (Robert Wesson Fellow in Scientific Philosophy and Public Policy)
More than an hour into last night’s debate, Rep. Michele Bachmann attacked Gov. Rick Perry on the HPV vaccination controversy — or more accurately pseudo-controversy...
August 31, 2011 | Forbes.com
news » hoover daily report

Precaution Without Principle

by Henry I. Miller (Robert Wesson Fellow in Scientific Philosophy and Public Policy) and Alan McHughen
[The application of the precautionary principle] often fails to consider that the status quo is not risk-free and that excessive regulation has costs and can result in an actual increase of risk if important new products and technologies are delayed or abandoned...
August 30, 2011 | Defining Ideas (Hoover Institution)
news » hoover daily report

The Perils of Price Controls

by Richard A. Epstein (Peter and Kirsten Bedford Senior Fellow and member of the Property Rights, Freedom, and Prosperity Task Force)
Why is there a shortage of cancer drugs in the United States...?
August 3, 2011 | Forbes.com
news » hoover daily report

Feds’ “Gotcha” Regulation Is Out Of Control

by Henry I. Miller (Robert Wesson Fellow in Scientific Philosophy and Public Policy)
Instead of trying to improve the FDA’s dismal performance — which has caused drug approvals to plummet while boosting the costs of drug development and the time required for clinical trials — regulators are ramping up efforts to intimidate and harass industry...